Ever Source Wealth Advisors, LLC Ultragenyx Pharmaceutical Inc. Transaction History

Ever Source Wealth Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 04, 2023	SELL	$37.35 - $52.15 $448 - $625	-12 Reduced 32.43%	25 $1,000
Q1 2023 May 11, 2023	BUY	$36.99 - $48.71 $1,368 - $1,802	37 New	37 $1,000
Q2 2022 Aug 01, 2022	SELL	$45.8 - $85.4 $3,160 - $5,892	-69 Reduced 81.18%	16 $0
Q1 2022 May 25, 2022	SELL	$62.2 - $84.4 $4,105 - $5,570	-66 Reduced 43.71%	85 $7,000
Q4 2021 Feb 07, 2022	BUY	$73.71 - $87.86 $11,130 - $13,266	151 New	151 $13,000

326

85.7M

520K

406K

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.01B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

Get notified when there are updates to the investment portfolio of Ever Source Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Ever Source Wealth Advisors, LLC with notifications on news.